The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease

In simple terms

This study looked at how thyroid antibodies changed in people with Graves' disease while they were on medicine, and noticed that those whose antibodies dropped faster were more likely to get better. But it didn't make anyone take the medicine — it just watched what happened, so we can't say the antibody drop caused the improvement.

63%

Analysis score

63/ 72

Maximum 72 for a cohort study.

Where the score came from

Reporting40

Methodology45

Publication100

Statistical77

Study type (basis of the score)

Cohort Study

Level 2b - Individual cohort study

What’s the bottom line?

Doctors use a blood test called TSI to see how active Graves' disease is. This study looked at whether how much that test number goes down in the first year of treatment can tell if the disease will come back later.

Where does this study sit?

Reviews of RCTs (Meta-analyses)

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5

StrongerWeaker

Cohort Studies

Level 2b

63 / 100

Quality score

Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.

Cannot establish causation

Save studies & get personalized insights

Create a free account to save this study, track new evidence as it comes in, and get breakdowns of studies in the topics you care about.

Key takeaways

Summary

Based on the study abstract and findings.

1Yes — if TSI doesn't drop quickly during treatment, it's a strong sign the disease might return even after stopping medicine, helping doctors decide when to stop treatment.
2Of 156 patients, 74 (47%) had the disease come back.
3Those whose TSI dropped a lot (average drop of 120 units) stayed well; those whose TSI barely dropped (average drop of 85 units) were more likely to relapse.

Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data